FDA 483 Citations for Quality Control Procedures Under 21 CFR 111.103

23 hours ago

4 min read

"You did not establish written procedures for quality control operations." FDA investigators cited 21 CFR 111.103 with that wording 54 times on system-generated Form FDA 483s in fiscal year 2025.

Part 111 gives quality control personnel a defined job: approve or reject specifications, procedures, components, batches and returns. When quality control has no written procedures, those decisions are inconsistent or missing, and the investigator often finds other gaps, such as unapproved specifications or batches released without review.

What the citation means

Examples written after "Specifically" usually describe:

No written procedures describing quality control responsibilities
No procedure for material review and disposition decisions
No procedure for approving or rejecting reprocessing
Quality control duties performed by production staff without defined authority
Specifications, MMRs or procedures in use without quality control approval
Batches released without documented quality control review
Out-of-specification results handled informally

What Part 111 requires

Written procedures (111.103). You must establish and follow written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision, and for approving or rejecting any reprocessing.

Quality control responsibilities (111.105 to 111.140). Quality control personnel must ensure that manufacturing, packaging, labeling and holding operations ensure the quality of the dietary supplement and that it is packaged and labeled as specified in the master manufacturing record. Their duties include:

Approving or rejecting all processes, specifications, written procedures, controls, tests and examinations, and deviations from or modifications to them, that may affect identity, purity, strength or composition
Reviewing the results of required tests and examinations and ensuring they are documented
Approving or rejecting components, packaging, labels, in-process material and finished batches
Conducting material reviews and making disposition decisions when specifications are not met or something unexpected occurs (111.113)
Approving or rejecting reprocessing and returned dietary supplements (111.130)
Reviewing and approving the investigation of product complaints (111.135)
Reviewing laboratory operations, calibration and equipment records (111.110 and 111.117)

Quality control personnel (111.12 and 111.13). You must have qualified people to perform quality control, and the quality control unit must be identified, although one person can perform quality control and other functions if they are qualified and the duties are kept distinct.

How to respond to the 483

Part 111 does not set a deadline for responding, but most firms respond in writing within 15 business days of the close of the inspection, so FDA has the response before it decides on further action.

Define the quality control unit

Name the quality control personnel, their qualifications and their authority. If one person has other duties, state how independence of quality control decisions is protected.

Write the procedures

Quality control responsibilities, mapped to each Part 111 section
Review and approval of specifications, MMRs and procedures
Component, packaging and label approval
Batch record review and release
Material review and disposition
Reprocessing approval
Out-of-specification investigation
Returned products and complaint investigations

Approve what is already in use

Have quality control review and approve, or revise, specifications, MMRs and procedures in use. Review recent batch releases and material decisions.

Train and verify

Train quality control staff and the people who hand work to them. Audit quality control records after the change.

What a compliant quality control procedure set contains

Organization and authority of quality control
Duties under 111.105 to 111.140
Material review and disposition
Reprocessing
Batch release
Laboratory oversight and out-of-specification handling
Records and signatures

Common mistakes in quality control responses

Writing a procedure that names quality control duties without giving anyone authority
Leaving production staff to release batches
Approving specifications in bulk without reviewing them
Treating out-of-specification results as retests until something passes
Forgetting returned goods and complaints

Example: how one response section might read

This illustrates structure only; your response must describe your own facts.

Observation 7: You did not establish written procedures for quality control operations. Specifically, no procedures describe how material reviews and disposition decisions are made.

Response:

Correction: Quality control procedures covering responsibilities, material review and disposition, reprocessing approval and batch release were issued on a stated date.
Organization: The quality control manager and two technicians were designated as quality control personnel with documented authority to reject material and batches.
Retrospective review: Twelve undocumented disposition decisions from the past year were reviewed by quality control and documented.
Training: Quality control, production and warehouse staff were trained.
Verification: An internal audit of quality control records will be performed after three months.

Frequently asked questions

Do we need a separate quality control department?

Part 111 requires quality control personnel and operations, not a separate department. In a small company, one qualified person may perform quality control along with other duties, but quality control decisions must be clearly documented.

Can contract manufacturers perform quality control for us?

They perform quality control for their own operations. A firm that holds, packages, labels or distributes product under its own name remains responsible for its own Part 111 obligations and should decide how its quality control approves the contract manufacturer's work.

What is a material review?

The documented evaluation and disposition decision made by quality control when a specification is not met, or when something unexpected occurs that may affect quality.

How A.P. Lyon documents help

A.P. Lyon's Dietary Supplement cGMP Quality System (21 CFR 111) includes quality control procedures for responsibilities, material review and disposition, reprocessing, batch release and laboratory oversight. The Supplement Brand Owner Compliance Pack covers quality control for brand owners who use contract manufacturers.

Documents are editable Word and Excel files and must be adapted to your organization and operations. Quality control personnel must be qualified and must follow the procedures.

Next steps

Name quality control personnel and define their authority
Write procedures for every quality control responsibility
Have quality control approve what is already in use
Respond in writing within 15 business days with dates for each action

To compare the complete system with the brand owner pack, see all dietary supplement documents.

Not sure where your quality system stands? Take the free QMS gap check: about 20 questions, an instant report of your gaps by clause, and the procedures that close each one.